BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25027605)

  • 1. Molecular dynamics study of the dominant-negative E219K polymorphism in human prion protein.
    Jahandideh S; Jamalan M; Faridounnia M
    J Biomol Struct Dyn; 2015; 33(6):1315-25. PubMed ID: 25027605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
    Rossetti G; Giachin G; Legname G; Carloni P
    Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the protective effect of the human prion protein carrying the dominant-negative E219K polymorphism.
    Biljan I; Giachin G; Ilc G; Zhukov I; Plavec J; Legname G
    Biochem J; 2012 Sep; 446(2):243-51. PubMed ID: 22676969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR structural studies of human cellular prion proteins.
    Biljan I; Ilc G; Giachin G; Legname G; Plavec J
    Curr Top Med Chem; 2013; 13(19):2407-18. PubMed ID: 24059340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalent mutations of human prion protein: a molecular modeling and molecular dynamics study.
    Behmard E; Abdolmaleki P; Asadabadi EB; Jahandideh S
    J Biomol Struct Dyn; 2011 Oct; 29(2):379-89. PubMed ID: 21875156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic investigation of predicted effect of nonsynonymous SNPs in human prion protein gene: a molecular modeling and molecular dynamics study.
    Jahandideh S; Zhi D
    J Biomol Struct Dyn; 2014; 32(2):289-300. PubMed ID: 23527686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
    Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
    J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico analysis of prion protein mutants: a comparative study by molecular dynamics approach.
    Doss CG; Rajith B; Rajasekaran R; Srajan J; Nagasundaram N; Debajyoti C
    Cell Biochem Biophys; 2013; 67(3):1307-18. PubMed ID: 23723004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the A117V mutation on the folding and aggregation of palindromic sequences (PrP113-120) in prion: insights from replica exchange molecular dynamics simulations.
    Ning L; Wang Q; Zheng Y; Liu H; Yao X
    Mol Biosyst; 2015 Feb; 11(2):647-55. PubMed ID: 25483828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational studies on prion proteins: effect of Ala(117)-->Val mutation.
    Okimoto N; Yamanaka K; Suenaga A; Hata M; Hoshino T
    Biophys J; 2002 May; 82(5):2746-57. PubMed ID: 11964260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras.
    Cong X; Bongarzone S; Giachin G; Rossetti G; Carloni P; Legname G
    J Biomol Struct Dyn; 2013; 31(8):829-40. PubMed ID: 22934595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One gene, two diseases and three conformations: molecular dynamics simulations of mutants of human prion protein at room temperature and elevated temperatures.
    Shamsir MS; Dalby AR
    Proteins; 2005 May; 59(2):275-90. PubMed ID: 15739202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexibility of the murine prion protein and its Asp178Asn mutant investigated by molecular dynamics simulations.
    Gsponer J; Ferrara P; Caflisch A
    J Mol Graph Model; 2001; 20(2):169-82. PubMed ID: 11775003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions.
    Zuegg J; Gready JE
    Biochemistry; 1999 Oct; 38(42):13862-76. PubMed ID: 10529232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders.
    Peoc'h K; Levavasseur E; Delmont E; De Simone A; Laffont-Proust I; Privat N; Chebaro Y; Chapuis C; Bedoucha P; Brandel JP; Laquerriere A; Kemeny JL; Hauw JJ; Borg M; Rezaei H; Derreumaux P; Laplanche JL; Haïk S
    Hum Mol Genet; 2012 Dec; 21(26):5417-28. PubMed ID: 22965875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition Mechanisms between a Nanobody and Disordered Epitopes of the Human Prion Protein: An Integrative Molecular Dynamics Study.
    Mollica L; Giachin G
    J Chem Inf Model; 2023 Jan; 63(2):531-545. PubMed ID: 36580661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding.
    van der Kamp MW; Daggett V
    J Mol Biol; 2010 Dec; 404(4):732-48. PubMed ID: 20932979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural rearrangements at physiological pH: nuclear magnetic resonance insights from the V210I human prion protein mutant.
    Biljan I; Ilc G; Giachin G; Plavec J; Legname G
    Biochemistry; 2012 Sep; 51(38):7465-74. PubMed ID: 22947063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.